secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001193125-24-032871
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aileron approves $204K bonus for President/COO Brian Windsor for FY 2023
------------------------------------------------------------------------

- Board approved a $204,375 performance-based cash bonus for Brian Windsor (President and COO) for FY 2023.
- The bonus updates Windsor's 2023 Summary Compensation Table; total compensation becomes $289,642.
- No other named executive officers received a performance-based cash bonus for FY 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524032871/0001193125-24-032871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524032871/d780523d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-032871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer